Cited by 533Obstructive Sleep Apnea ResearchSleep and related disordersSleep and Work-Related Fatigue

The Effect of CPAP in Normalizing Daytime Sleepiness, Quality of Life, and Neurocognitive Function in Patients with Moderate to Severe OSA

Open access
Antic, Nick A., Catcheside, Peter, Buchan, Catherine, Hensley, Michael, Naughton, Matthew T., Rowland, Sharn, Williamson, Bernadette, Windler, Samantha +1 more·2011·Sleep

Abstract

STUDY OBJECTIVES: The study aimed to document the neurobehavioral outcomes of patients referred to and treated by a sleep medicine service for moderate to severe obstructive sleep apnea (OSA). In particular, we aimed to establish the proportion of patients who, while appearing to have optimal continuous positive airway pressure (CPAP) adherence, did not normalize their daytime sleepiness or neurocognitive function after 3 months of CPAP therapy despite effective control of OSA. DESIGN: Multicenter clinical-effectiveness study. SETTING: Three academic sleep centers in Australia. PARTICIPANTS: Patients referred to a sleep medicine service with moderate to severe OSA (n = 174). INTERVENTION: CPAP. MEASUREMENTS AND RESULTS: Participants were assessed pretreatment and again after 3 months of CPAP therapy. At the beginning and at the conclusion of the trial, participants completed a day of testing that included measures of objective and subjective daytime sleepiness, neurocognitive function, and quality of life. In patients with symptomatic moderate to severe OSA (i.e., apnea-hypopnea index > 30/h), we found a treatment dose-response effect for CPAP in terms of Epworth Sleepiness Scale scores (P < 0.001). Several key indexes of neurobehavior (e.g., Functional Outcomes of Sleep Questionnaire, Epworth Sleepiness Scale) currently used to assess treatment response failed to normalize in a substantial group of patients after 3 months of CPAP treatment, even in those who were maximally compliant with treatment. Forty percent of patients in this trial had an abnormal Epworth Sleepiness Scale score at the conclusion of the trial. In addition, we showed no dose-response effect with the Maintenance of Wakefulness Test, raising doubts as to the clinical utility of the Maintenance of Wakefulness Test in assessing treatment response to CPAP in patients with OSA. CONCLUSIONS: Our study suggests that a greater percentage of patients achieve normal functioning with longer nightly CPAP duration of use, but a substantial proportion of patients will not normalize neurobehavioral responses despite seemingly adequate CPAP use. It is thus crucial to adequately assess patients after CPAP therapy and seek alternate etiologies and treatments for any residual abnormalities.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/sleep/34.1.111

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Current evidence suggests a continuous dose-response relationship between hours of PAP use and therapeutic response.

    “current evidence suggests a continuous dose-response relationship between hours of use and therapeutic response.22,23”

    From Treatment of Adult Obstructive Sleep Apnea With Positive Airway Pressure: An American Academy of Sleep Medicine Systematic Review, Meta-Analysis, and GRADE Assessment (2019) · cites this paper as [22]

    The Discussion passage (page not provided) reports a dose-response relationship for many, but not all, behavioral measures: it was clear for posttreatment ESS scores but absent for MWT sleep latency. Thus the paper supports a relationship between hours of CPAP use and some therapeutic outcomes, but not a continuous relationship across therapeutic response generally. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • More time spent using CPAP leads to greater improvement in secondary manifestations of OSA such as sleepiness and quality of life.

    “While more time spent using CPAP leads to greater improvement in secondary manifestations of OSA such as sleepiness and quality of life, the incremental improvements achieved with one extra hour of CPAP treatment are small [49,50].”

    From Cognitive and behavioral therapy for insomnia increases the use of continuous positive airway pressure therapy in obstructive sleep apnea participants with comorbid insomnia: A randomized clinical trial (2019) · cites this paper as [50]

    The Methodologic Considerations section reports significantly greater improvement in sleepiness (ESS) and disease-specific quality of life (FOSQ) with greater CPAP adherence. The ESS Scores section supports greater sleepiness benefit with increasing use, but its estimated FOSQ change of 0.149 points per additional hour was not statistically significant. The paper therefore does not establish the sentence’s broader implication that each extra hour produces a small improvement in both outcomes. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • The incremental improvements achieved with one extra hour of CPAP treatment are small.

    “While more time spent using CPAP leads to greater improvement in secondary manifestations of OSA such as sleepiness and quality of life, the incremental improvements achieved with one extra hour of CPAP treatment are small [49,50].”

    From Cognitive and behavioral therapy for insomnia increases the use of continuous positive airway pressure therapy in obstructive sleep apnea participants with comorbid insomnia: A randomized clinical trial (2019) · cites this paper as [50]

    In the ESS Scores section (page unavailable), the paper estimates a small FOSQ change of 0.149 points per additional hour of CPAP use, but says that association was not statistically significant. It reports greater ESS benefit with increasing use, without establishing that the sleepiness improvement from one extra hour is small. (LLM, conf=0.81)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Antic, N. A., Catcheside, P., Buchan, C., Hensley, M., Naughton, M. T., Rowland, S., Williamson, B., Windler, S., & McEvoy, R. D.
Affiliations
  • Flinders University (AU)
  • The Alfred Hospital (AU)
  • John Hunter Hospital (AU)
  • Repatriation General Hospital (AU)
Venue
Sleep
Published
2011-01
Volume
34
Issue
1
Pages
111-119
ISSN
  • 0161-8105 (ISSN-L)
  • 1550-9109
OpenAlex
W199424036
Cited by
533
References
33
Citations by year
2026: 17 · 2025: 21 · 2024: 26 · 2023: 36 · 2022: 56 · 2021: 45 · 2020: 50 · 2019: 41 · 2018: 43 · 2017: 39 · 2016: 36 · 2015: 38 · 2014: 27 · 2013: 31 · 2012: 16
FWCI
18.54
Type
journal article
Language
en
Open access
Locations
  • SLEEP (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • NOVA (University of Newcastle Australia) (submittedVersion)
Funders
  • ResMed
  • Masimo
  • Medical Research Council
  • National Health and Medical Research Council
Topics
  • Health Sciences › Medicine › Physiology › Obstructive Sleep Apnea Research
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and Work-Related Fatigue
Keywords
obstructive sleep apnea, CPAP therapy, daytime sleepiness, neurocognitive function, quality of life, Epworth Sleepiness Scale, maintenance of wakefulness test, CPAP adherence, treatment response assessment, dose-response relationship
MeSH terms
Cognition, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Patient Compliance, Quality of Life, Surveys and Questionnaires, Sleep, Wakefulness, Treatment Outcome, Sleep Apnea, Obstructive, Continuous Positive Airway Pressure

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review